Literature DB >> 30144000

Graft-versus-host disease (GvHD) of the tongue and of the oral cavity: a large retrospective study.

Andrea Piccin1,2,3, Mario Tagnin4,5, Cinzia Vecchiato6,4, Ahmad Al-Khaffaf6,4, Lisa Beqiri5, Caroline Kaiser5, Iris Agreiter4, Giovanni Negri4,7, Michael Kob4,8, Angela Di Pierro4, Fabio Vittadello4, Guido Mazzoleni4,7, Klaus Eisendle4, Fabrizio Fontanella4,5.   

Abstract

Graft-versus-host disease (GvHD) causes severe mucositis, impairs feeding and favors infection. The objective of this study was to identify the impact of GvHD in the oral cavity. We reviewed all consecutive patients who developed oral GvHD after HSCT. The study period was over 14 years. 53 patients were identified. M/F = 1.4; median age was 48.6 years; the median follow-up was for up to 3 years and 6 months. Conditioning regimens included several drugs (e.g., busulfan, cyclophosphamide and fludarabine). In 11 cases, radiotherapy (RT) was also used. Patients treated with RT were more likely to have tooth decay requiring fillings (p = 0.029), to need canal root interventions (p = 0.005) and to have tartar requiring oral hygiene interventions (p = 0.011). Patients with a lymphoma diagnosis were more likely to develop perioral scleroderma and chronic oral GvHD (cGvHD) (p = 0.045). Oral acute GvHD (aGvHD) was seen in 26 patients (49.1%). 21 (39.6%) patients developed cGvHD. GvHD of the tongue was seen in 21 (40%) patients. Oral mucositis was seen in only 5 patients (9.4%). Conditioning regimens with RT are more likely to induce oral aGvHD. The tongue is often affected by GvHD.

Entities:  

Keywords:  Chemotherapy; Graft-versus-host disease; HSCT; Lichen planus; Mucositis; Oral GvHD; Tongue GvHD

Mesh:

Substances:

Year:  2018        PMID: 30144000     DOI: 10.1007/s12185-018-2520-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  32 in total

1.  [Graft-versus-Host Disease (GvHD) - an update : Part 1: Pathophysiology, clinical features and classification of GvHD].

Authors:  R Travnik; M Beckers; D Wolff; E Holler; M Landthaler; S Karrer
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

2.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.

Authors:  J Douglas Rizzo; John R Wingard; Andre Tichelli; Stephanie J Lee; Maria Teresa Van Lint; Linda J Burns; Stella M Davies; James L M Ferrara; Gérard Socié
Journal:  Biol Blood Marrow Transplant       Date:  2006-02       Impact factor: 5.742

3.  Weight loss and reduced body mass index: a critical issue in children with multiorgan chronic graft-versus-host disease.

Authors:  B Browning; K Thormann; R Seshadri; R Duerst; M Kletzel; D A Jacobsohn
Journal:  Bone Marrow Transplant       Date:  2006-03       Impact factor: 5.483

4.  Oral cavity care in patients after high-dose chemotherapy and stem cell transplantation: the East Forum EBMT Nurses Group standard of care.

Authors:  E Bystricka; R Ghelase; I K S Gorican; E Mazur; S Vokurka
Journal:  Bone Marrow Transplant       Date:  2011-02-28       Impact factor: 5.483

5.  Oral health in children treated with bone marrow transplantation: a one-year follow-up.

Authors:  G Dahllöf; T Modéer; P Bolme; O Ringdén; A Heimdahl
Journal:  ASDC J Dent Child       Date:  1988 May-Jun

Review 6.  Are we making progress in GVHD prophylaxis and treatment?

Authors:  Steven Z Pavletic; Daniel H Fowler
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

7.  Energy and substrate metabolism in patients with chronic extensive graft-versus-host disease.

Authors:  C Zauner; W Rabitsch; B Schneeweiss; M Schiefermeier; H T Greinix; F Keil; K Ratheiser; P Kalhs
Journal:  Transplantation       Date:  2001-02-27       Impact factor: 4.939

8.  Weight loss and malnutrition in patients with chronic graft-versus-host disease.

Authors:  D A Jacobsohn; J Margolis; J Doherty; V Anders; G B Vogelsang
Journal:  Bone Marrow Transplant       Date:  2002-02       Impact factor: 5.483

9.  Solid cancers after bone marrow transplantation.

Authors:  R E Curtis; P A Rowlings; H J Deeg; D A Shriner; G Socíe; L B Travis; M M Horowitz; R P Witherspoon; R N Hoover; K A Sobocinski; J F Fraumeni; J D Boice
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

Review 10.  Advances in graft-versus-host disease biology and therapy.

Authors:  Bruce R Blazar; William J Murphy; Mehrdad Abedi
Journal:  Nat Rev Immunol       Date:  2012-05-11       Impact factor: 53.106

View more
  2 in total

Review 1.  Oral Chronic Graft-Versus-Host Disease.

Authors:  David Dean; Herve Sroussi
Journal:  Front Oral Health       Date:  2022-05-20

2.  The clinical application of partial removal periodontal surgery in the therapy of epulis.

Authors:  Yaqiao Zhu; Huihui Zhang; Chengzhang Li
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.